- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT03116763
The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis (iPeer2Peer)
24 ottobre 2022 aggiornato da: Jennifer Stinson, The Hospital for Sick Children
The iPeer2Peer Program for Adolescents With Juvenile Idiopathic Arthritis: A Randomized Controlled Trial
The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially.
This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).
Panoramica dello studio
Stato
Reclutamento
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Arthritis is a common childhood illness that makes everyday activities hard for young people.
It is a long-lasting illness that can make you feel pain, tired and emotionally upset.
This can make it hard for children and teens to see friends and do the activities that they like.
The goal of this project is to find out if the newly developed peer mentoring program called iPeer2Peer helps teens with arthritis take better care of their illness and feel more connected to other people with arthritis.
The iPeer2Peer program matches teens with arthritis to an older mentor who has learned to manage their arthritis well and can support them emotionally and socially.
This study will compare two groups of teens: those who are in the iPeer2Peer Program and those in the control group (no mentor).
Tipo di studio
Interventistico
Iscrizione (Anticipato)
262
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Stephanie Luca, HBSc, MA
- Numero di telefono: 309133 416-813-7654
- Email: stephanie.luca@sickkids.ca
Luoghi di studio
-
-
Alberta
-
Calgary, Alberta, Canada, T3B 6A8
- Non ancora reclutamento
- Alberta Children's Hospital
-
Contatto:
- Nadia Luca, MD
- Email: Nadia.Luca@albertahealthservices.ca
-
-
British Columbia
-
Vancouver, British Columbia, Canada
- Reclutamento
- BC Children's Hospital
-
Contatto:
- Lori Tucker, MD
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada
- Reclutamento
- The IWK Health Centre
-
Contatto:
- Adam Huber, MSc, MD
-
-
Ontario
-
London, Ontario, Canada, N6A 5W9
- Non ancora reclutamento
- Children's Hospital - London Health Sciences
-
Contatto:
- Roberta Berard, MD
- Email: Roberta.Berard@lhsc.on.ca
-
Ottawa, Ontario, Canada
- Reclutamento
- Children's Hospital of Eastern Ontario (CHEO)
-
Contatto:
- Ciaran Duffy, MSc, FRCPC
-
Contatto:
- Karen Watanabe Duffy, MD, FRCPC
-
Sub-investigatore:
- Paula Forgeron, MD
-
Sub-investigatore:
- Karen Watanabe Duffy, MD, FRCPC
-
Toronto, Ontario, Canada
- Reclutamento
- The Hospital for Sick Children
-
Contatto:
- Jennifer Stinson, CPNP, PhD
-
Sub-investigatore:
- Sara Ahola Kohut, PhD, CPsych
-
Sub-investigatore:
- Brian Feldman, MD, FRCPC
-
Sub-investigatore:
- Lynn Spiegel, MD, FRCPC
-
Sub-investigatore:
- Myla Moretti, PhD
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
Da 12 anni a 18 anni (Bambino, Adulto)
Accetta volontari sani
No
Sessi ammissibili allo studio
Tutto
Descrizione
Inclusion Criteria:
- males and females 12-18 years old
- rheumatologist-diagnosed JIA according to ILAR criteria
- able to speak and read English
- access to a computer, smartphone or tablet capable of using free Skype software (note: participants who do not have adequate Internet access will be provided with portable Internet sticks)
- willing and able to complete online measures.
Exclusion Criteria:
- significant cognitive impairments
- major co-morbid illnesses (medical or psychiatric conditions) likely to influence HRQL assessment
- participating in other peer support or self-management interventions.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
---|---|
Sperimentale: iPeer2Peer Mentorship
In addition to standard care, youth in the experimental group will receive the iPeer2Peer program, a peer mentorship program that will provide modeling and reinforcement of self-management by pre-screened and trained peer mentors (young adults with JIA aged 18-22 years who have learned to function successfully with their disease).
Mentors will encourage participants to develop and engage in self-management skills and provide social support.
|
10 sessions of 20-30 minute Skype calls conducted over 5-12 weeks.
|
Comparatore attivo: Control Group
The control group will receive standard care but without the iPeer2Peer program.
|
The control group will receive standard care but without the iPeer2Peer program.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
TRANSITION-Q (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
14-item measure of self-management skills that is both reliable (internally consistent, test-retest) and valid (face, construct and content validity)
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
---|---|---|
PedsQL Arthritis Module (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Health-related quality of life
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
PROMIS Pain Interference (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Pain
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Screen for Child Anxiety Related Disorders (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Emotional distress
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Center for Epidemiologic Studies Depression Scale Revised (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Emotional distress
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Medical Issues, Exercise, Pain and Social Support Questionnaire (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Disease knowledge
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Children's Arthritis Self-Efficacy (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Self-efficacy
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
PROMIS Pediatric Peer Relationship Scale (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Perceived social support
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
AQoL-6D, interview (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Cost utility analysis
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Health service use and costs (measuring change)
Lasso di tempo: Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Cost utility analysis
|
Baseline; Immediately following interview (approximately 12 weeks after baseline); 6-months post
|
Mentor Behavior Scale (measuring change)
Lasso di tempo: Post-Intervention (approximately following 12 weeks of calls)
|
Mentor quality
|
Post-Intervention (approximately following 12 weeks of calls)
|
PROMIS Adult Profile (measuring change)
Lasso di tempo: At beginning of study and at end of study (approximately 3 years later)
|
For mentors only: mentor physical and emotional symptoms
|
At beginning of study and at end of study (approximately 3 years later)
|
PROMIS Satisfaction with Social Roles and Activities (measuring change)
Lasso di tempo: At beginning of study and at end of study (approximately 3 years later)
|
For mentors only: perceived social role satisfaction
|
At beginning of study and at end of study (approximately 3 years later)
|
Chronic Disease Self-Efficacy Scale (measuring change)
Lasso di tempo: At beginning of study and at end of study (approximately 3 years later)
|
For mentors only: self-efficacy
|
At beginning of study and at end of study (approximately 3 years later)
|
Mentor interaction form
Lasso di tempo: Following completion of each mentee's calls (approximately following 12 weeks of calls)
|
Record of interactions with mentees
|
Following completion of each mentee's calls (approximately following 12 weeks of calls)
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Jennifer N Stinson, CPNP, PhD, The Hospital for Sick Children
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Effettivo)
28 marzo 2017
Completamento primario (Anticipato)
31 maggio 2023
Completamento dello studio (Anticipato)
30 settembre 2023
Date di iscrizione allo studio
Primo inviato
31 marzo 2017
Primo inviato che soddisfa i criteri di controllo qualità
11 aprile 2017
Primo Inserito (Effettivo)
17 aprile 2017
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
25 ottobre 2022
Ultimo aggiornamento inviato che soddisfa i criteri QC
24 ottobre 2022
Ultimo verificato
1 ottobre 2022
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 1000054878
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su iPeer2Peer Mentorship
-
The Hospital for Sick ChildrenBritish Columbia Children's Hospital; University of Alberta/Stollery Children... e altri collaboratoriReclutamentoArresto cardiacoCanada
-
The Hospital for Sick ChildrenChildren's Hospital of Eastern Ontario; Royal University Hospital Foundation; Connecticut...Attivo, non reclutanteAnemia falciformeStati Uniti, Canada
-
The Hospital for Sick ChildrenCompletatoMalattie infiammatorie intestinaliCanada
-
The Hospital for Sick ChildrenEnduring Hearts; University of Alberta/Stollery Children's HospitalCompletato